The elusive role of endometrial progenitor cells in immunoregulation and regenerative medicine: A brief review of current knowledge

In: Romanian Medical Journal · 2021 · vol. 68(S6) , pp. 7–10 · doi:10.37897/rmj.2021.s6.1 · W4285314978
review OA: gold CC0
AI-generated summary by gemini-2.5-flash-lite, 2026-06-09

This review outlines the characteristics of endometrial stem/progenitor cells, summarizing their roles in immunoregulation, regenerative medicine, and endometriosis, and proposing therapeutic strategies for reproductive and cancerous diseases.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

The human endometrium is a highly regenerative organ undergoing over 400 cycles of shedding and regeneration over a woman’s lifetime. This massive regenerative capacity is thought to have a stem cell basis, with human endometrial stromal stem cells having already been extensively studied. Endometrial stem cells can be divided into three categories: endometrial epithelial stem/progenitor cells, CD140b+CD146+ or SUSD2+ endometrial mesenchymal stem cells (eMSCs), and side population cells (SPs). Endometrial stem/progenitor cells in the menstruation blood are defined as menstrual stem cells (MenSCs). Due to their abundant sources, excellent proliferation rate, and self-transplantation capabilities, MenSCs are ideal candidates for cell-based therapy in regenerative medicine, inflammation, and immune-related diseases. In this manuscript we review the available literature and outline the characteristics of endometrial stem/progenitor cells, summarizing their roles in immunoregulation, regenerative medicine and endometriosis, through which we provide some novel therapeutic strategies for reproductive and cancerous diseases.

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (3)

References (21)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK